Fate Therapeutics
FATE
FATE
272 hedge funds and large institutions have $8.19B invested in Fate Therapeutics in 2021 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 101 increasing their positions, 77 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 259 → 272 (+13)
0.45% more ownership
Funds ownership: 99.98% → 100.43% (+0.45%)
36% less call options, than puts
Call options by funds: $13.5M | Put options by funds: $21.1M
Holders
272
Holding in Top 10
13
Calls
$13.5M
Puts
$21.1M
Top Buyers
| 1 | +$80.6M | |
| 2 | +$75.8M | |
| 3 | +$53.9M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$40.8M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$39.5M |
Top Sellers
| 1 | -$163M | |
| 2 | -$89.8M | |
| 3 | -$49.3M | |
| 4 |
Two Sigma Investments
New York
|
-$31.8M |
| 5 |
Morgan Stanley
New York
|
-$22.4M |